FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Allele: Dmel\sraKO
Open Close
General Information
Symbol
Dmel\sraKO
Species
D. melanogaster
Name
FlyBase ID
FBal0194818
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Key Links
Nature of the Allele
Progenitor genotype
Associated Insertion(s)
Cytology
Description

Part of the sra gene has been replaced by a w+* marker.

Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 0 )
Disease
Evidence
References
Modifiers Based on Experimental Evidence ( 0 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
 
Disease-implicated variant(s)
 
Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

sraKO heterozygote adults display mild rough-eye phenotype compared to controls.

sraKO flies move throughout a 24 hour period and are approximately twofold more active than wild-type flies in both LD and DD conditions. Heterozygous sraKO mutants have identical activity to wild-type flies.

Compared to wild-type flies, sraKO flies show a dramatic loss of sleep, to approximately 30% of wild-type amounts. This result is also observed in DD conditions.

Walking activity is slightly decreased in LD conditions in sraKO mutants, while it is only slightly increased in DD conditions. The increase in daily activity of sraKO mutants is due to increased time spent in a walking state, rather than to increased activity during walking.

The number of daily sleep bouts is the same in sraKO mutants and wild-type flies, in both LD and DD conditions. In contrast, the average sleep bout length in sraKO mutants is decreased to approximately 30% that of wild-type, in LD and DD conditions, indicating that decreased sleep in sraKO is due to a decrease in sleep maintenance, rather than to a decrease in sleep onset.

sraGS3080/sraKO mutants exhibit a precipitous decrease in time spent asleep, approximately one third of the amount of wild-type sleep.

sraKO flies tend to die much earlier than wild-type flies.

The defective egg hatching phenotype resulting from the mis-expression of sraS215A.Scer\UAS.P\T under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 is strongly enhanced by sraKO heterozygosity.

The rate of egg hatching appears normal as a result of sraS219A.Scer\UAS.P\T expression driven by Scer\GAL4nos.UTR.T:Hsim\VP16. The rate of egg hatching is reduced by sraKO heterozygosity.

Approximately 70% of sraKO individuals develop to the adult stage, but these adults have shorter lives than control flies. Virgin females show spontaneous ovulation.

The ovaries of sraKO females appear morphologically normal but eggs from sraKO mothers arrest in anaphase I of meiosis I and fail to hatch. Eggs from sraKO germline clones also arrest at anaphase I.

External Data
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
Suppressed by
Statement
Reference
Enhancer of
Suppressor of
Statement
Reference
Other
Phenotype Manifest In
Suppressor of
Statement
Reference
Other
Additional Comments
Genetic Interactions
Statement
Reference

The severe small and rough eye phenotype observed in flies expressing Hsap\APPAβ42.Scer\UAS.cBa under the control of Scer\GAL4GMR.PU is significantly ameliorated by combination with sraKO in heterozygous state.

A CanA-14FKO background partially suppresses the reduction in total sleep found in sraGS3080/sraKO mutants.

A Pp2B-14DKO background partially suppresses the reduction in total sleep found in sraGS3080/sraKO mutants.

Heterozygosity for sraKO enhances the lethality resulting from the overexpression of Pp2B-14DDN.Scer\UAS.P\T in the female germ-line driven by Scer\GAL4nos.UTR.T:Hsim\VP16. Most of the mutant cells fail to complete meiosis. Defects in these eggs vary from oocyte to oocyte, but a large number of eggs lack a characteristic structure of polar bodies known as the rosette structure formed after two rounds of meiotic division. This strong genetic interaction is not observed by overexpression of Pp2B-14DScer\UAS.P\T.cTa.

Xenogenetic Interactions
Statement
Reference
Complementation and Rescue Data
Comments

Expression of sraScer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 rescues the female sterility and meiotic phenotype seen in sraKO mutants. 95.6% of the laid eggs are able to complete meiosis.

Expression of sraS67A.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 rescues the meiotic phenotype seen in sraKO mutants. 87.9% of eggs are able to complete meiosis.

Expression of sraS72A.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 rescues the meiotic phenotype seen in sraKO mutants. 97.6% of eggs are able to complete meiosis.

Expression of sraS100A.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 rescues the meiotic phenotype seen in sraKO mutants. All eggs are able to complete meiosis.

Expression of sraT102A.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 rescues the meiotic phenotype seen in sraKO mutants. All eggs are able to complete meiosis.

Expression of sraT196A.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 rescues the meiotic phenotype seen in sraKO mutants. 97.1% of eggs are able to complete meiosis.

Expression of sraS215A.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 fails to rescue the meiotic phenotype seen in sraKO mutants. No eggs are able to complete meiosis. Expressing sraS215A.Scer\UAS.P\T.T:Zzzz\FLAG in a sraKO/+ background results in only 8% of eggs hatching and meiotic defects are observed.

Expression of sraS219A.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 partially rescues the meiotic phenotype seen in sraKO mutants. Only 26.2% of eggs are able to complete meiosis.

Expression of sraT246A.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 rescues the meiotic phenotype seen in sraKO mutants. 93.2% of eggs are able to complete meiosis.

Expression of sraS199A.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 rescues the meiotic phenotype seen in sraKO mutants. 86.2% of eggs are able to complete meiosis.

Expression of sraS215D.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 fails to rescue the meiotic phenotype seen in sraKO mutants. No eggs are able to complete meiosis.

Expression of sraS215E.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 fails to rescue the meiotic phenotype seen in sraKO mutants. No eggs are able to complete meiosis.

Expression of sraS219D.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 partially rescues the meiotic phenotype seen in sraKO mutants. 60.0% of eggs are able to complete meiosis.

Expression of sraS219E.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 partially rescues the meiotic phenotype seen in sraKO mutants. 71.9% of eggs are able to complete meiosis.

Expression of sraScer\UAS.cEa in the nervous system under the control of Scer\GAL4elav.PLu restores the increased locomotor activity found in sraKO mutants back to wild-type levels. Similarly, sleep is completely restored to wild-type amounts in this genotype. Concurrent with this, a wild-type lifespan is also restored.

sraS215A.Scer\UAS.P\T driven by Scer\GAL4nos.UTR.T:Hsim\VP16 fails to restore female fertility or meiotic phenotype in sraKO homozygotes.

sraΔ212-221.Scer\UAS.P\T driven by Scer\GAL4nos.UTR.T:Hsim\VP16 fails to restore female fertility or meiotic phenotype in sraKO homozygotes.

sraS219A.Scer\UAS.P\T driven by Scer\GAL4nos.UTR.T:Hsim\VP16 partially restores female fertility or meiotic phenotype in sraKO homozygotes. Meiosis is completed completed and synchronous mitotic division is observed in about 11% of the mutant eggs. The remaining eggs exhibit multiple aster-free spindle phenotypes.

The sraScer\UAS.P\T.cTa transgene, when driven by Scer\GAL4nos.UTR.T:Hsim\VP16, is able to rescue the semilethality and the spontaneous ovulation phenotypes of sraKO females, but can only partially rescue the female sterility.

The srahs.PT transgene is not able to rescue the female sterility of sraKO flies.

Images (0)
Mutant
Wild-type
Stocks (1)
Notes on Origin
Discoverer
External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (1)
Reported As
Name Synonyms
Secondary FlyBase IDs
    References (6)